Tatva Chintan Pharma Chem Ltd
₹1052.40
(-4.55%)
Wed, 01 Apr 2026, 06:07 pm
Process Industries
Chemicals: Specialty
24.5KTatva Chintan Pharma Chem Enterprise Value (EV)
| Particulars | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 0 | 51.75 | 81.23 | 81.41 | 278 |
| Price to book ratio | 0 | 0 | 0 | 0 | 10.81 | 7.18 | 3.43 | 2.15 |
| Price to sales ratio | 0 | 0 | 0 | 0 | 11.46 | 8.73 | 6.29 | 4.16 |
| Price to cash flow ratio | 0 | 0 | 0 | 0 | 248.85 | 149.56 | 26.07 | 66.54 |
| Enterprise value | 0 | 0 | 0 | 0 | 49.04B | 38.2B | 24.37B | 16.1B |
| Enterprise value to EBITDA ratio | 0 | 0 | 0 | 0 | 45.09 | 56.60 | 35.93 | 43.86 |
| Debt to equity ratio | 0.95 | 0.97 | 0.77 | 0.54 | 0.25 | 0.33 | 0.02 | 0.05 |
| Return on equity % | 0 | 29.60 | 38.29 | 36.85 | 30.01 | 9.21 | 4.85 | 0.77 |
Tatva Chintan Pharma Chem Ltd Enterprise Value
The Tatva Chintan Pharma Chem Ltd Enterprise Value is a key financial metric used by investors to evaluate Tatva Chintan Pharma Chem Ltd's valuation, profitability, and overall financial performance. Tracking the Tatva Chintan Pharma Chem Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Tatva Chintan Pharma Chem Ltd (NSE: TATVA, BSE: 543321) is currently trading at ₹1052.40, with a market capitalization of ₹24.58B. As a leading company in the Process industries sector and Chemicals: specialty industry, monitoring the Tatva Chintan Pharma Chem Ltd Enterprise Value is essential for fundamental analysis.
Tatva Chintan Pharma Chem Ltd Enterprise Value Current Value
The current Tatva Chintan Pharma Chem Ltd Enterprise Value stands at 16.1B.
The Tatva Chintan Pharma Chem Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Tatva Chintan Pharma Chem Ltd Enterprise Value Historical Trend
The Tatva Chintan Pharma Chem Ltd Enterprise Value has shown the following historical trend:
- 2024: 16.1B
- 2023: 24.37B
- 2022: 38.2B
- 2021: 49.04B
- 2020: 0
The decline in Tatva Chintan Pharma Chem Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.
What Tatva Chintan Pharma Chem Ltd Enterprise Value Indicates for Investors
The Tatva Chintan Pharma Chem Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Tatva Chintan Pharma Chem Ltd.
Tatva Chintan Pharma Chem Ltd Enterprise Value Analysis Summary
The Tatva Chintan Pharma Chem Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Tatva Chintan Pharma Chem Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Tatva Chintan Pharma Chem Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800